Status
Conditions
Treatments
Study type
Funder types
Identifiers
About
The purpose of the study is to assess the outcomes of Physiologic Insulin Resensitization (PIR) treatment compared to standard of care (SOC) on patients with a diagnosis of Type 2 diabetes mellitus (T2DM). Participants will be in this study for 24 to 26 weeks.
Full description
This study will include two cohorts. The assessments include a three-hour intravenous glucose tolerance test (IVGTT) for insulin sensitivity and two types of imaging. The PIR cohort will undergo these assessments at baseline, 12 weeks, and 24 weeks, plus one additional IVGTT at 26 weeks. In addition, the PIR group will be required to undergo a three-hour infusion of insulin once or twice every week for weeks 0-24. The control cohort will undergo insulin sensitivity and body composition assessments at baseline,12 weeks, and 24 weeks.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Is 18 or older (male or female)
Have a documented diagnosis of T2DM of 6 months or greater prior to screening and an HbA1c >7.5. Patients may have treatment regimens associated with T2DM that include diabetic oral and/or injectable medications including insulin and/or GLP-1 receptor agonists.
In the opinion of the Investigator, has been on an appropriate, stable regimen for management of any complications present for the past six (6) months.
In the opinion of the Investigator, is able to do all of the following:
If female, the subject must meet either of the following sets of conditions:
Exclusion criteria
Has in the past two (2) years received treatment for a malignancy.
Current pregnancy or intends to become pregnant during the study
Has in the past one (1) year used non-prescription opioids or non- prescriptive psychoactive drugs.
Has in the past six (6) months had a hypoglycemic event requiring urgent care and/or administration of glucagon, osteocalcin, or parenteral glucose, unless approved for enrollment by the Medical Monitor.
Has within the past one (1) month participated in a clinical study involving either of the following:
Is nursing or is planning to nurse during the study.
Has - in the opinion of the Investigator - psychiatric, behavioral, cognitive and/or clinical dysfunction (whether or not related to known medical illness or drug / alcohol use) that would affect the subject's safety and/or compliance.
Is on active dialysis at time of screening
Weighs more than 450 lbs or has a waist circumference that exceeds the size of the MR bore when the coil is placed
Has had recent iodine or barium-based contrast imaging
Has an implanted device with metal incompatible with MR scanning, or the presence of any other metal in the body (such as shrapnel)
Is unable to remain still for extended periods of time or to hold breath for 10 seconds
Is claustrophobic.
Primary purpose
Allocation
Interventional model
Masking
60 participants in 2 patient groups
Loading...
Central trial contact
Harper Basquill, RN
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal